Avita Medical Ltd. 获签为期十年、价值高达2550万美元的Barda协议,强化美国烧伤应急准备

美股速递
Apr 09

Avita Medical Ltd. (RCEL) 已正式获得一项为期十年的合作协议,该协议由美国生物医学高级研究与发展管理局(Barda)授予,潜在总价值高达2550万美元。此项重要合作旨在显著增强美国应对大规模烧伤紧急事件的准备能力。

根据协议条款,Avita Medical 将负责确保其专有的再生医学技术平台——RECELL® 系统的持续研发、生产及供应保障。该协议不仅为公司的长期发展提供了稳定的资金支持,更凸显了其技术在国家级公共卫生应急储备中的关键战略价值。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10